Home › Funds › GMO Beyond China ETF
Fund family: GMO ETF Trust · Filed by GMO ETF Trust (CIK 1981627) · SEC series S000088547
Ticker: BCHI (C000254839)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,094 with, 0 against, 4 abstentions (not counted as with management); 50 items carried no recommendation. Shareholder proposals: 8 FOR, 21 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other GMO ETF Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
| Proposal type | Items | Against management |
|---|---|---|
| Corporate Governance | 414 | 0 |
| Director Elections | 369 | 0 |
| Capital Structure | 157 | 0 |
| Compensation | 120 | 0 |
| Audit-related | 60 | 0 |
| Other | 18 | 0 |
| Extraordinary Transactions | 7 | 0 |
| Other Social Issues | 2 | 0 |
| Shareholder Rights and Defenses | 1 | 0 |
1,148 ballot items at 136 meetings in 2025-2026. Download all votes (CSV)
In the 2025-2026 proxy season, GMO Beyond China ETF (BCHI) voted at 136 shareholder meetings of 90 companies, on 1,148 ballot items in all. Where management made a recommendation, the fund followed it on 99.6% of the items and voted against it 0 times. It voted on 29 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.